Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masataka Okamoto

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Cancer Science|March 4, 2014
Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathwaysHarumi Kato, Kennosuke Karube, Kazuhito Yamamoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 3, 2014
A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapyAkinao Okamoto, Akihiro Abe, Masataka Okamoto, et al.
The American Journal of Pathology|April 12, 2002
Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular featuresHiroshi Inagaki, John K C Chan, Josephine W M Ng, et al.
Blood|January 25, 2002
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patientsMotoko Yamaguchi, Masao Seto, Masataka Okamoto, et al.
Cancer Science|April 24, 2010
Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patientsKazuyuki Shimada, Takuhei Murase, Kosei Matsue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in JapanKazuyuki Shimada, Kosei Matsue, Kazuhito Yamamoto, et al.
Cancer Medicine|July 28, 2023
Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseasesChisako Iriyama, Kenichiro Murate, Sachiko Iba, et al.
Haematologica|June 17, 2008
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patientsMotoko Yamaguchi, Naoya Nakamura, Ritsuro Suzuki, et al.
Blood|September 9, 2010
Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysisDaisuke Ennishi, Yoshinobu Maeda, Nozomi Niitsu, et al.
International Journal of Hematology|November 16, 2010
Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305)Michinori Ogura, Kuniaki Itoh, Tomohiro Kinoshita, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Cancer Science|March 4, 2014
Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathwaysHarumi Kato, Kennosuke Karube, Kazuhito Yamamoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 3, 2014
A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapyAkinao Okamoto, Akihiro Abe, Masataka Okamoto, et al.
The American Journal of Pathology|April 12, 2002
Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular featuresHiroshi Inagaki, John K C Chan, Josephine W M Ng, et al.
Blood|January 25, 2002
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patientsMotoko Yamaguchi, Masao Seto, Masataka Okamoto, et al.
Cancer Science|April 24, 2010
Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patientsKazuyuki Shimada, Takuhei Murase, Kosei Matsue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in JapanKazuyuki Shimada, Kosei Matsue, Kazuhito Yamamoto, et al.
Cancer Medicine|July 28, 2023
Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseasesChisako Iriyama, Kenichiro Murate, Sachiko Iba, et al.
Haematologica|June 17, 2008
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patientsMotoko Yamaguchi, Naoya Nakamura, Ritsuro Suzuki, et al.
Blood|September 9, 2010
Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysisDaisuke Ennishi, Yoshinobu Maeda, Nozomi Niitsu, et al.
International Journal of Hematology|November 16, 2010
Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305)Michinori Ogura, Kuniaki Itoh, Tomohiro Kinoshita, et al.
Pageof 7